Titre:
  • Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib.
Auteur:Meeus, P.; Demuynck, H; Martiat, Philippe; Michaux, Lucienne; Wouters, E; Hagemeijer, Anne
Informations sur la publication:Leukemia, 17, 2, page (465-467)
Statut de publication:Publié, 2003-02
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- therapeutic use
Chromosome Aberrations
Female
Humans
In Situ Hybridization, Fluorescence
Karyotyping
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- pathology
Male
Middle Aged
Philadelphia Chromosome
Piperazines -- adverse effects
Piperazines -- therapeutic use
Pyrimidines -- adverse effects
Pyrimidines -- therapeutic use
Time Factors
Note générale:Case Reports
Letter
SCOPUS: le.j
Langue:Anglais
Identificateurs:urn:issn:0887-6924
info:doi/10.1038/sj.leu.2402791
info:pii/2402791
info:scp/0344626927
info:pmid/12592350